nach oben

European Journal of Nuclear Medicine and Molecular Imaging

Erschienen in:

01.09.2004 | Controversies-For

Primary hyperparathyroidism: is there a role for imaging?

verfasst von: Rudolf Roka, Michael Pramhas, Sebastian Roka

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 9/2004

Einloggen, um Zugang zu erhalten

Excerpt

“The best means of localisation is an experienced surgeon.” Although this sentiment can sometimes be found in publications, preoperative localisation of pathological parathyroid glands is a permanent endeavour. The reasons are obvious. With correct preoperative localisation, quick and guided identification of parathyroid adenomas can be achieved by the surgeon. This is especially important for reoperative surgery or in the presence of ectopic glands. Furthermore, operative time and surgical trauma are minimised, in accordance with the general trend within endocrine and other branches of surgery towards minimally invasive surgical techniques. …

Fritsch A, Roka R, Niederle B. Operatives Vorgehen beim primären Hyperparathyreoidismus. In: Fritsch A, Geyer G, editors. Hyperparathyreoidismus. Diagnostik und Therapie der Nebenschilddrüsenüberfunktion. Wien: Urban und Schwarzenberg; 1982.

Wang C. The anatomic basis of parathyroid surgery. Ann Surg 1976;183(3):271–5.PubMed

Arici C, Cheah WK, Ituarte PH, et al. Can localization studies be used to direct focused parathyroid operations? Surgery 2001;129(6):720–9.CrossRefPubMed

Casara D, Rubello D, Pelizzo MR, Shapiro B. Clinical role of^99mTcO4/MIBI scan, ultrasound and intra-operative gamma probe in the performance of unilateral and minimally invasive surgery in primary hyperparathyroidism. Eur J Nucl Med 2001;28(9):1351–9.CrossRefPubMed

Hindie E, Melliere D, Jeanguillaume C, Urena P, deLabriolle Vaylet C, Perlemuter L. Unilateral surgery for primary hyperparathyroidism on the basis of technetium Tc 99m sestamibi and iodine 123 subtraction scanning. Arch Surg 2000;135(12):1461–8.CrossRefPubMed

Miccoli P, Monchik JM. Minimally invasive parathyroid surgery. Surg Endosc 2000;14(11):987–90.CrossRefPubMed

Peeler BB, Martin WH, Sandler MP, Goldstein RE. Sestamibi parathyroid scanning and preoperative localization studies for patients with recurrent/persistent hyperparathyroidism or significant comorbid conditions: development of an optimal localization strategy. Am Surg 1997;63(1):37–46.PubMed

Shen W, Duren M, Morita E, et al. Reoperation for persistent or recurrent primary hyperparathyroidism. Arch Surg 1996;131(8):861–7.PubMed

Gotway MB, Reddy GP, Webb WR, Morita ET, Clark OH, Higgins CB. Comparison between MR imaging and^99mTc MIBI scintigraphy in the evaluation of recurrent of persistent hyperparathyroidism. Radiology 2001;218(3):783–90.PubMed

10.

Shen W, Sabanci U, Morita ET, Siperstein AE, Duh QY, Clark OH. Sestamibi scanning is inadequate for directing unilateral neck exploration for first-time parathyroidectomy. Arch Surg 1997;132(9):969–74.PubMed

11.

Wakamatsu H, Noguchi S, Yamashita H, et al. Technetium-99m tetrofosmin for parathyroid scintigraphy: a direct comparison with^99mTc-MIBI,²⁰¹Tl, MRI and US. Eur J Nucl Med 2001;28(12):1817–27.CrossRefPubMed

12.

Walgenbach S, Dulkowski P, Andreas J, Görges R, Bockisch A, Junginger T.^99mTc-MIBI-Szintigraphie vor Eingriffen wegen Hyperparathyreoidismus? Zentralbl Chir 1999;124:214–9.PubMed

13.

Joseph K, Welcke U, Hoffken H, Koppelberg T, Rothmund M. Szintigraphische Darstellung von Adenomen der Nebenschilddruse mit^99mTc-Sestamibi in einem Strumaendemiegebiet. Nuklearmedizin 1994;33(3):93–8.PubMed

14.

Weiss M, Beneke F, Schmid R, Dresel S, Hahn K. Kann durch den zusatzlichen Einsatz der SPECT-Technik die diagnostische Aussage der praoperativen Tc-99m-MIBI-Szintigraphie beim primaren Hyperparathyreoidismus verbessert werden? Med Klin (Munich) 2002;97(7):389–95.CrossRef

15.

Profanter C, Wetscher GJ, Gabriel M, et al. CT-MIBI image fusion: a new preoperative localization technique for primary, recurrent, and persistent hyperparathyroidism. Surgery 2004;135(2):157–62.CrossRefPubMed

16.

Mundschenk J, Klose S, Lorenz K, Dralle H, Lehnert H. Diagnostic strategies and surgical procedures in persistent or recurrent primary hyperparathyroidism. Exp Clin Endocrinol Diabetes 1999;107(6):331–6.PubMed

17.

Thompson GB, Grant CS, Perrier ND, et al. Reoperative parathyroid surgery in the era of sestamibi scanning and intraoperative parathyroid hormone monitoring. Arch Surg 1999;134(7):699–704.CrossRefPubMed

18.

Boggs JE, Irvin GL III, Molinari AS, Deriso GT. Intraoperative parathyroid hormone monitoring as an adjunct to parathyroidectomy. Surgery 1996;120(6):954–8.PubMed

19.

Reeve TS, Babidge WJ, Parkyn RF, et al. Minimally invasive surgery for primary hyperparathyroidism: systematic review. Arch Surg 2000;135(4):481–7.CrossRefPubMed

20.

Greene AK, Mowschenson P, Hodin RA. Is sestamibi-guided parathyroidectomy really cost-effective? Surgery 1999;126(6):1036–40.CrossRefPubMed

21.

Passler C, Avanessian R, Kaczirek K, et al. Schilddrüsenchirurgie im Alter. Eur Surg—Acta Chirurgica Austriaca 2001;33(6):288–93.CrossRef

Titel: Primary hyperparathyroidism: is there a role for imaging?
verfasst von: Rudolf Roka
Michael Pramhas
Sebastian Roka
Publikationsdatum: 01.09.2004
Verlag: Springer-Verlag
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 9/2004
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-004-1619-5

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 9/2004

Imaging of human sodium-iodide symporter gene expression mediated by recombinant adenovirus in skeletal muscle of living rats

Clinical utility of co-registered respiratory-gated 99mTc-Technegas/MAA SPECT-CT images in the assessment of regional lung functional impairment in patients with lung cancer

Molecular targeting of angiogenesis for imaging and therapy

Positron emission tomography imaging of adrenal masses: 18F-fluorodeoxyglucose and the 11β-hydroxylase tracer 11C-metomidate

Intracoronary brachytherapy for in-stent restenosis: will it remain a viable therapy?

Pancreatic cancer or chronic pancreatitis? An answer from PET/MRI image fusion